Literature DB >> 21279531

Staphylococcus aureus skin and soft tissue infections in primary healthcare in Denmark: a 12-year population-based study.

M Dalager-Pedersen1, M Søgaard, H C Schønheyder.   

Abstract

A rise in community-onset Staphylococcus aureus infections has been observed in European countries. To ascertain secular trends of S. aureus infections in primary healthcare in Denmark, we conducted this register-based study in the North Denmark region, during the period 1997-2008. We identified all skin and mucosa specimens obtained by general practitioners and all prescriptions for the preferred oral anti-staphylococcal antibiotic, dicloxacillin. Repeat observations within a 12-month period were excluded prior to the calculation of age and gender standardised incidence rates per 100,000 person-years. We included 108,758 specimens, of which 42,778 (39%) yielded S. aureus. The annual incidence rate of specimens doubled during the study period, reaching 2,399 in 2008. The overall rate of S. aureus isolates increased 2-fold to a stable rate at about 850, but for isolates from children and for impetigo specimens, the increase was steeper, with a peak in 2002. A total of 156,462 dicloxacillin prescriptions had been redeemed and the annual prescription rate increased 2.5-fold, peaking at 3,714 in 2007. In conclusion, the annual rates of specimens, S. aureus infections and dicloxacillin prescriptions more than doubled in primary healthcare during the 12-year study period. A major impetigo epidemic and calls for antibiotic stewardship with increased utilisation of specimens were contributing factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279531     DOI: 10.1007/s10096-011-1179-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Tentative interpretative zone diameters for fusidic acid Neosensitabs on Mueller Hinton agar and three blood containing media.

Authors:  Robert Skov; Niels Frimodt-Møller; Frank Espersen
Journal:  Int J Antimicrob Agents       Date:  2003-11       Impact factor: 5.283

2.  Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.

Authors:  A Osterlund; G Kahlmeter; S Haeggman; B Olsson-Liljequist
Journal:  Scand J Infect Dis       Date:  2006

3.  Impetigo: incidence and treatment in Dutch general practice in 1987 and 2001--results from two national surveys.

Authors:  S Koning; R S A Mohammedamin; J C van der Wouden; L W A van Suijlekom-Smit; F G Schellevis; S Thomas
Journal:  Br J Dermatol       Date:  2006-02       Impact factor: 9.302

4.  The Pharmacoepidemiologic Prescription Database of North Jutland - a valid tool in pharmacoepidemiological research.

Authors:  G L Nielsen; H T Sørensen; W Zhou; F H Steffensen; J Olsen
Journal:  Int J Risk Saf Med       Date:  1997

5.  Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid.

Authors:  A Osterlund; T Eden; B Olsson-Liljequist; S Haeggman; G Kahlmeter
Journal:  Scand J Infect Dis       Date:  2002

6.  A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.

Authors:  Alexander J O'Neill; Anders R Larsen; Anne S Henriksen; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  Skin infections and antibiotic prescribing: a comparison of surveillance and prescribing data.

Authors:  Douglas M Fleming; Alex J Elliot; Helen Kendall
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

8.  Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.

Authors:  S Rørtveit; G Rortveit
Journal:  Br J Dermatol       Date:  2007-06-06       Impact factor: 9.302

9.  Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections.

Authors:  A R Larsen; R L Skov; V Jarlier; A S Henriksen
Journal:  J Antimicrob Chemother       Date:  2008-01-25       Impact factor: 5.790

10.  The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland.

Authors:  M Denton; B O'Connell; P Bernard; V Jarlier; Z Williams; A Santerre Henriksen
Journal:  J Antimicrob Chemother       Date:  2008-01-25       Impact factor: 5.790

View more
  5 in total

1.  An in vitro Study on the Apoptosis Inducing Effects of Ultraviolet B light in Staphylococcus aureus.

Authors:  Elham Behzadi; Payam Behzadi
Journal:  Maedica (Buchar)       Date:  2012-01

2.  Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use.

Authors:  Fawziah Marra; David M Patrick; Mei Chong; Rachel McKay; Linda Hoang; William R Bowie
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

3.  Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.

Authors:  Theodore Rosen; Nuria Albareda; Noah Rosenberg; Fernando García Alonso; Sandra Roth; Ilonka Zsolt; Adelaide A Hebert
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

4.  Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010.

Authors:  Laura J Shallcross; Irene Petersen; Joe Rosenthal; Anne M Johnson; Nick Freemantle; Andrew C Hayward
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

5.  The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.

Authors:  Sverre Rørtveit; Dag Harald Skutlaberg; Nina Langeland; Guri Rortveit
Journal:  Scand J Infect Dis       Date:  2014-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.